<VariationArchive VariationID="627051" VariationName="NM_000130.5(F5):c.2862del (p.Ser955fs)" VariationType="Deletion" Accession="VCV000627051" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-15" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="615280" VariationID="627051">
      <GeneList>
        <Gene Symbol="F5" FullName="coagulation factor V" GeneID="2153" HGNC_ID="HGNC:3542" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169511951" stop="169586481" display_start="169511951" display_stop="169586481" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169481191" stop="169555768" display_start="169481191" display_stop="169555768" Strand="-" />
          </Location>
          <OMIM>612309</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000130.5(F5):c.2862del (p.Ser955fs)</Name>
      <CanonicalSPDI>NC_000001.11:169542227:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169511466" stop="169511466" display_start="169511466" display_stop="169511466" variantLength="1" positionVCF="169511465" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169542228" stop="169542228" display_start="169542228" display_stop="169542228" variantLength="1" positionVCF="169542227" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>F5, 1-BP DEL, 2952T</Name>
      </OtherNameList>
      <ProteinChange>S955fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.169511466del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.169511466del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.169542228del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.169542228del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011806.1" sequenceAccession="NG_011806" sequenceVersion="1" change="g.49304del">
            <Expression>NG_011806.1:g.49304del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000130.5" sequenceAccession="NM_000130" sequenceVersion="5" change="c.2862del" MANESelect="true">
            <Expression>NM_000130.5:c.2862del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000121.2" sequenceAccession="NP_000121" sequenceVersion="2" change="p.Ser955fs">
            <Expression>NP_000121.2:p.Ser955fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_553" sequenceAccession="LRG_553">
            <Expression>LRG_553:g.49304del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000130.4" sequenceAccession="NM_000130" sequenceVersion="4" change="c.2862delT">
            <Expression>NM_000130.4:c.2862delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="612309.0010" DB="OMIM" />
        <XRef Type="rs" ID="765982916" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000130.5(F5):c.2862del (p.Ser955fs) AND Factor V deficiency" Accession="RCV000851763" Version="2">
        <ClassifiedConditionList TraitSetID="169">
          <ClassifiedCondition DB="MedGen" ID="C4317320">Factor V deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000130.5(F5):c.2862del (p.Ser955fs) AND Congenital factor V deficiency" Accession="RCV003596549" Version="1">
        <ClassifiedConditionList TraitSetID="88526">
          <ClassifiedCondition DB="MedGen" ID="C0015499">Congenital factor V deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-12" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11781258</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30924984</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="169" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1267" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Reduced coagulation factor V activity</ElementValue>
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Factor V deficiency</ElementValue>
                <XRef ID="Factor+V+Deficiency/2709" DB="Genetic Alliance" />
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0020586" DB="MONDO" />
                <XRef ID="4320005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep vein thrombosis (DVT) is the most common VTE, with the legs being the most common site. Thrombosis in unusual locations is less common. Evidence suggests that heterozygosity for the Leiden variant has at most a modest effect on risk for recurrent thrombosis after initial treatment of a first VTE. It is unlikely that factor V Leiden thrombophilia (i.e., heterozygosity or homozygosity for the Leiden variant) is a major factor contributing to pregnancy loss and other adverse pregnancy outcomes (preeclampsia, fetal growth restriction, and placental abruption). The clinical expression of factor V Leiden thrombophilia is influenced by the following: The number of Leiden variants (heterozygotes have a slightly increased risk for venous thrombosis; homozygotes have a much greater thrombotic risk). Coexisting genetic thrombophilic disorders, which have a supra-additive effect on overall thrombotic risk. Acquired thrombophilic disorders: antiphospholipid antibody (APLA) syndrome, paroxysmal nocturnal hemoglobinuria, myeloproliferative disorders, and increased levels of clotting factors. Circumstantial risk factors including but not limited to pregnancy, central venous catheters, travel, combined oral contraceptive (COC) use and other combined contraceptives, oral hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), obesity, leg injury, and advancing age.</Attribute>
                <XRef ID="NBK1368" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301542</ID>
                <ID Source="BookShelf">NBK1368</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2011">
                <ID Source="PubMed">21150787</ID>
              </Citation>
              <Citation Type="general" Abbrev="Retired, ACMG, 2001">
                <ID Source="pmc">3111091</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="ACMG, 2021">
                <ID Source="PubMed">33674767</ID>
              </Citation>
              <Citation Type="general" Abbrev="BSH, 2022">
                <ID Source="PubMed">35645034</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng158</URL>
                <CitationText>UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023</CitationText>
              </Citation>
              <XRef ID="326" DB="Orphanet" />
              <XRef ID="C4317320" DB="MedGen" />
              <XRef ID="MONDO:0020586" DB="MONDO" />
              <XRef Type="primary" ID="HP:0003225" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="88526" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61064" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital factor V deficiency</ElementValue>
                <XRef ID="MONDO:0009210" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OWREN PARAHEMOPHILIA</ElementValue>
                <XRef Type="MIM" ID="227400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARAHEMOPHILIA</ElementValue>
                <XRef Type="MIM" ID="227400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary factor V deficiency disease</ElementValue>
                <XRef ID="88776002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LABILE FACTOR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="227400" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2237" />
                <XRef ID="2237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="326" DB="Orphanet" />
              <XRef ID="C0015499" DB="MedGen" />
              <XRef ID="MONDO:0009210" DB="MONDO" />
              <XRef Type="MIM" ID="227400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20836" SubmissionDate="2013-04-01" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612309.0010_FACTOR V DEFICIENCY" title="F5, 1-BP DEL, 2952T_FACTOR V DEFICIENCY" />
        <ClinVarAccession Accession="SCV000020836" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-01-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male infant with severe bleeding tendency and undetectable factor V activity (227400), Ajzner et al. (2002) found compound heterozygosity for 2 mutations in the F5 gene: a 1-bp deletion in exon 13 (2952delT) and a 1-bp insertion in exon 16 (5493insG; 612309.0011). Both mutations introduced a frameshift and a premature stop at codons 930 and 1776, respectively. The proband's father and mother were heterozygous for the 2 mutations, respectively. Both mutations resulted in the synthesis of truncated proteins lacking complete light chain or its C-terminal part.</Attribute>
              <Citation>
                <ID Source="PubMed">11781258</ID>
              </Citation>
              <XRef DB="OMIM" ID="227400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5" />
          </GeneList>
          <Name>F5, 1-BP DEL, 2952T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2952T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612309.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FACTOR V DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1769292" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.2862delT_227400" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899650" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0007</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000130.4:c.2862delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227400" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7977728" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4821087|MedGen:C0015499" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293800" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11781258</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30924984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30924984</ID>
          </Citation>
          <Comment>This variant is also known as 2952delT. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 627051). This premature translational stop signal has been observed in individual(s) with autosomal recessive factor V deficiency (PMID: 11781258, 30924984). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs765982916, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Ser955Alafs*4) in the F5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in F5 are known to be pathogenic (PMID: 30924984).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.169511466del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0015499" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7977728" TraitType="Disease" MappingType="XRef" MappingValue="C0015499" MappingRef="MedGen">
        <MedGen CUI="C0015499" Name="Congenital factor V deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20836" TraitType="Disease" MappingType="Name" MappingValue="FACTOR V DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C4317320" Name="Factor V deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769292" TraitType="Disease" MappingType="XRef" MappingValue="227400" MappingRef="OMIM">
        <MedGen CUI="C0015499" Name="Congenital factor V deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

